These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 29625265)
1. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer. Zhao H; Li H Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265 [TBL] [Abstract][Full Text] [Related]
2. Identification of key genes and miRNAs markers of papillary thyroid cancer. Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611 [TBL] [Abstract][Full Text] [Related]
3. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis. Qu T; Li YP; Li XH; Chen Y Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685 [TBL] [Abstract][Full Text] [Related]
4. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis. Yu J; Mai W; Cui Y; Kong L J Endocrinol Invest; 2016 Nov; 39(11):1285-1293. PubMed ID: 27250077 [TBL] [Abstract][Full Text] [Related]
5. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis. Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912 [TBL] [Abstract][Full Text] [Related]
6. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis. Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327 [TBL] [Abstract][Full Text] [Related]
7. Competing endogenous RNA regulatory network in papillary thyroid carcinoma. Chen S; Fan X; Gu H; Zhang L; Zhao W Mol Med Rep; 2018 Jul; 18(1):695-704. PubMed ID: 29767230 [TBL] [Abstract][Full Text] [Related]
8. Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer. Bansal R; Saxena U Appl Biochem Biotechnol; 2023 May; 195(5):2917-2932. PubMed ID: 36445679 [TBL] [Abstract][Full Text] [Related]
9. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma. Han J; Chen M; Wang Y; Gong B; Zhuang T; Liang L; Qiao H Sci Rep; 2018 Jul; 8(1):9912. PubMed ID: 29967488 [TBL] [Abstract][Full Text] [Related]
10. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis. Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of a set of microRNA genes reveals the potential mechanism of papillary thyroid carcinoma. Feng Z; Song Y; Qian J; Chen T; Yang C; Jia L; Liu C; Liu P; Lv J; Deng Z Ann Endocrinol (Paris); 2019 Apr; 80(2):77-83. PubMed ID: 30685058 [TBL] [Abstract][Full Text] [Related]
12. Identification of Genes Associated with Papillary Thyroid Carcinoma (PTC) for Diagnosis by Integrated Analysis. Li WB; Zhou J; Xu L; Su XL; Liu Q; Pang H Horm Metab Res; 2016 Apr; 48(4):226-31. PubMed ID: 26756467 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of potential target genes in papillary thyroid cancer. Zhang K; Liu J; Li C; Peng X; Li H; Li Z Eur J Pharmacol; 2019 Jan; 843():217-225. PubMed ID: 30472204 [TBL] [Abstract][Full Text] [Related]
14. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma. Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295 [TBL] [Abstract][Full Text] [Related]
15. Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis. Liang W; Sun F J Endocrinol Invest; 2018 Oct; 41(10):1237-1245. PubMed ID: 29520684 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis. Zhang H; Teng X; Liu Z; Zhang L; Liu Z J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589 [TBL] [Abstract][Full Text] [Related]
17. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer. Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing. Wen DY; Pan DH; Lin P; Mo QY; Wei YP; Luo YH; Chen G; He Y; Chen JQ; Yang H Mol Med Rep; 2018 Sep; 18(3):2631-2642. PubMed ID: 30015845 [TBL] [Abstract][Full Text] [Related]
19. Identification of potential targetable genes in papillary, follicular, and anaplastic thyroid carcinoma using bioinformatics analysis. Agarwal S; Gupta S; Raj R Endocrine; 2024 Oct; 86(1):255-267. PubMed ID: 38676768 [TBL] [Abstract][Full Text] [Related]
20. Identification of differentially expressed genes and signaling pathways in papillary thyroid cancer: a study based on integrated microarray and bioinformatics analysis. Sun T; Guan Q; Wang Y; Qian K; Sun W; Ji Q; Wu Y; Guo K; Xiang J Gland Surg; 2021 Feb; 10(2):629-644. PubMed ID: 33708546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]